Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05130580 · ClinicalTrials.gov registry record · NA

Patient-Specific Decision Aid System for Shared Decision Making About Breast Reconstruction

A NA study of Breast Carcinoma, sponsored by M.D. Anderson Cancer Center.

Active
Registry status
NA
Development phase
35
Enrollment target
1
Study location

NCT05130580: Active NA study of Breast Carcinoma, sponsored by M.D. Anderson Cancer Center.

NCT05130580 is a NA study of Breast Carcinoma that is active but no longer recruiting, run by M.D. Anderson Cancer Center. The registered enrollment target is 35 participants, below the 770-participant average among 106 other Breast Carcinoma trials with a reported enrollment target (95% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05130580, a NA study of Breast Carcinoma, is active but no longer recruiting, sponsored by M.D. Anderson Cancer Center.

ACTIVE NOT RECRUITING
Registry status
NA
Development phase
35 participants
Enrollment target
1
Study location

Study Summary

This clinical trial evaluates whether a decision aid application (app) is effective in helping breast reconstruction surgery patients make informed decisions about breast reconstruction surgery. Researchers have created a computer app for breast reconstruction surgery patients that presents images of breast reconstruction outcomes that are customized to the individual patient's treatment options and personal preferences. This decision aid app may help educate patients about how they might look after surgery and answer their questions.

Conditions Studied

Interventions

  • OTHER Questionnaire Administration
  • OTHER Educational Intervention
  • OTHER Enhanced Consultation
  • OTHER Standard of Care Consultation
  • PROCEDURE Conventional Imaging

Study Locations (1)

Texas

  • M D Anderson Cancer Center - Houston

Trial Details

FieldValue
Enrollment Target 35 participants
Start Date 2020-10-13
Est. Completion 2027-02-02
Phase NA
M.D. Anderson Cancer Center

2,692 total trials

What the registry record for NCT05130580 still lists

NCT05130580 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 35 participants, a relatively small participant target, below the 770-participant average among 106 other Breast Carcinoma trials with a reported enrollment target (95% lower).

The record links to 1 condition, with Breast Carcinoma appearing as the primary indexed condition, and to 5 interventions - of which Questionnaire Administration is the first listed.

NCT05130580 reports a single indexed study location in Texas.

Frequently Asked Questions

What is clinical trial NCT05130580 about?

NCT05130580 is a clinical study titled "Patient-Specific Decision Aid System for Shared Decision Making About Breast Reconstruction". This clinical trial evaluates whether a decision aid application (app) is effective in helping breast reconstruction surgery patients make informed decisions about breast reconstruction surgery. Researchers have created a computer app for breast reconstruction surgery patients that presents images o...

What is the current status of trial NCT05130580?

This trial is currently active not recruiting. It is a NA study. The enrollment target is 35 participants. The study started on 2020-10-13. Estimated completion is 2027-02-02.

What conditions does trial NCT05130580 study?

This clinical trial studies the following conditions: Breast Carcinoma.

What interventions are being tested in trial NCT05130580?

The interventions under investigation include: Questionnaire Administration (OTHER), Educational Intervention (OTHER), Enhanced Consultation (OTHER), Standard of Care Consultation (OTHER), Conventional Imaging (PROCEDURE).

Who is sponsoring clinical trial NCT05130580?

This trial is sponsored by M.D. Anderson Cancer Center, which has 2,692 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05130580 being conducted?

This trial has 1 study location across Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Breast Carcinoma

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT05130580's enrollment target sits among peer trials

35 85th of 106 higher than 22 of 106 other Breast Carcinoma trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Breast Carcinoma trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT01697371 · 35 participants · NA

    Proton Therapy in the Treatment of Liver Metastases

  • NCT01940757 · 35 participants · Phase 1

    Experimental Infection of Hookworm-naïve Adults With Dermally-applied Infectious Necator Americanus Hookworm Larvae

  • NCT02235857 · 35 participants · NA

    Post Approval Study of Liposorber LA-15 System for the Treatment of Focal Segmental Glomerulosclerosis in Children

  • NCT02637934 · 35 participants · Phase 1

    Phase I Pilot Study of Biodistribution, Metabolism and Excretion of Novel Radiotracer [18F]Fluorthanatrace (FTT) by PET/CT

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT05130580, the US trial registry maintained by the National Library of Medicine. NCT05130580 (small enrollment · single site footprint · active not recruiting) retrieved and formatted by PlainTrial, see methodology.